This inventor holds 10 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: The Ohio State University, Aalborg University, Regents of the University of Minnesota. Active years: 2011-2023.
Location History:
- Upper Arlington, OH (US) (2020)
- Columbus, OH (US) (2011 - 2023)
Company Filing History:
10 out of 1,573 
1 out of 43 
1 out of 2,364 
Years Active: 2011-2023
Title: Ramiro Garzon: Innovator in Biotechnology
Introduction
Ramiro Garzon is a prominent inventor based in Columbus, OH (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapies and treatments. With a total of 10 patents to his name, Garzon's work has had a substantial impact on medical research and applications.
Latest Patents
Among his latest patents are "Recombinant EGFL7, EGFL7 antibodies, and uses thereof," which focuses on the development of recombinant proteins and their therapeutic applications. Another notable patent is "Materials and methods for modifying the activity of T cells," which provides miRNA/mRNA pairs that can enhance or modulate T cell efficacy, thereby restoring immune equilibrium.
Career Highlights
Garzon has worked with esteemed institutions such as The Ohio State University and the Ohio State Innovation Foundation. His research has been pivotal in advancing our understanding of immune responses and developing new therapeutic strategies.
Collaborations
Throughout his career, Garzon has collaborated with notable scientists, including Carlo M. Croce and George A. Calin. These partnerships have further enriched his research and contributed to the success of his innovations.
Conclusion
Ramiro Garzon's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence medical research and therapeutic development.